(MedPage Today) — A pill formation, a stronger injectable, and more cash payment options: lots of changes are coming to the GLP-1 drug market. (NBC News)
The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119296
Author :
Publish date : 2026-01-06 18:00:00
Copyright for syndicated content belongs to the linked Source.
